SCA Pharmaceuticals Recalls Products Due to Potential Contamination

The company is recalling several injectable products because of possible microbial contamination.
Oct 23, 2017
By Pharmaceutical Technology Editors

On Oct. 20, 2017, SCA Pharmaceuticals LLC announced it was voluntarily recalling several lots of injectable products to the hospital level because of a potential for microbial contamination.  The recalled products were distributed nationwide to hospitals.

The recalled products include Succinylcholine Chloride 20 mg/mL 10 mL syringe, Fentanyl 2 mcg/mL + Bupivacaine 0.125% in 250 mL 0.9% Sodium Chloride, Oxytocin 30 units added to 500 mL Lactated Ringers, and Calcium Gluconate 2 g added to 50 mL 0.9% Sodium Chloride. A complete list of recalled products can be found on FDA’s website.

While the company has not received any reports of adverse events as of the date of the recall, it cautions that using products that are intended to be sterile but may be contaminated may result in serious or even life-threatening infections. The company stated in a press release that patients should contact their healthcare provider if they experience any problems associated with the recalled products. Adverse events may be reported to FDA via their website

Source: FDA

native1_300x100
lorem ipsum